cbdMD (YCBD) Net Equity Issued and Repurchased (2017 - 2024)
cbdMD (YCBD) posted Net Equity Issued and Repurchased of $1.0 for Q3 2024, down 99.98% sequentially from $4253.0 in Q3 2023, and down 99.98% YoY from $4253.0 in Q4 2023.
cbdMD (YCBD) Net Equity Issued and Repurchased (2017 - 2024) Analysis & Trends
cbdMD has reported Net Equity Issued and Repurchased for 7 years, with the latest figure at $1.0 in Q3 2024.
- Quarterly Net Equity Issued and Repurchased fell 99.98% year-over-year to $1.0 in Q3 2024, while the trailing twelve-month figure through Sep 2025 was $1.0 (down 100.0% YoY) and the FY2024 annual result came in at $50001.0, down 97.98% from the prior year.
- Net Equity Issued and Repurchased slipped to $1.0 in Q3 2024 per YCBD's latest filing, from $4253.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $22.3 million in Q1 2021 and troughed at -$2.2 million in Q3 2020.
- A 4-year average of $5.6 million and a median of $4253.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
- The sharpest annual moves came in 2021 and 2024: Net Equity Issued and Repurchased surged 32.96% in 2021, then slumped 99.98% in 2024.
- Over 4 years, Net Equity Issued and Repurchased stood at -$242744.0 in 2020, then jumped by 9286.63% to $22.3 million in 2021, then slumped by 99.98% to $4253.0 in 2023, then plunged by 99.98% to $1.0 in 2024.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $1.0, $4253.0, and $2.5 million for Q3 2024, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.00 |
| Sep 30, 2024 | 1.00 |
| Sep 30, 2023 | 4,253.00 |
| Sep 30, 2023 | 4,253.00 |
| Jun 30, 2023 | 2.47 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2021 | 22.30 Mn |
| Mar 31, 2021 | 22.30 Mn |
| Dec 31, 2020 | -242,744.00 |
| Dec 31, 2020 | -242,744.00 |
| Sep 30, 2020 | -2.24 Mn |
| Sep 30, 2020 | -2.24 Mn |
| Mar 31, 2020 | 16.77 Mn |
| Mar 31, 2020 | 16.77 Mn |
| Jun 30, 2019 | 12.65 Mn |
| Jun 30, 2019 | 12.65 Mn |
| Dec 31, 2018 | 6.36 Mn |
| Dec 31, 2018 | 6.36 Mn |
| Dec 31, 2017 | 10.93 Mn |
| Dec 31, 2017 | 10.93 Mn |